Skip to content
★ Sign in to follow
MP

Martin P. Rosendale

Nuo Therapeutics, Inc.
Total declarations
28
Company
1
▲ Purchases (16 ops.)
€67k
▼ Sales (0 ops.)
—

Latest filing published 21 Aug 2014 for Nuo Therapeutics, Inc., €7,541.

Insider track record

Disclosed buys
16
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
16

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Martin P. Rosendale: trading record in brief

Martin P. Rosendale discloses dealings in Nuo Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 3 April 2008 to 20 August 2014, the count stands at 28 filings.

Purchases make up the whole of the open-market record (16 purchases, €67k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. Since January 2014: 1 purchase and no sales on the market.

The median purchase comes to €2,074.

The latest filing, published on 21 August 2014, reports an open-market purchase of €7,541 in Nuo Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Martin P. Rosendale

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations26 total

25 of 26 declarations